Montecito Bank & Trust Catalent, Inc. Transaction History

Montecito Bank & Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$87.2 - $114.05 $523,723 - $684,984	-6,006 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$94.19 - $124.49 $2,825 - $3,734	30 Added 0.5%	6,006 $666,000
Q3 2021 Oct 28, 2021	SELL	$109.17 - $142.35 $3,493 - $4,555	-32 Reduced 0.53%	5,976 $795,000
Q2 2021 Jul 08, 2021	BUY	$100.34 - $115.69 $15,251 - $17,584	152 Added 2.6%	6,008 $650,000
Q1 2021 Apr 26, 2021	SELL	$101.51 - $125.27 $5,380 - $6,639	-53 Reduced 0.9%	5,856 $617,000

Q4 2020 Jan 28, 2021	BUY	$85.88 - $105.36 $507,464 - $622,572	5,909 New	5,909 $615,000

484

172M

865K

687K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.2B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Montecito Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Montecito Bank & Trust with notifications on news.